Tectonic Therapeutic
TECX
99 hedge funds and large institutions have $166M invested in Tectonic Therapeutic in 2021 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 34 increasing their positions, 27 reducing their positions, and 16 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 27
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
2% more funds holding
Funds holding: 97 → 99 (+2)
0.76% less ownership
Funds ownership: 6.46% → 5.7% (-0.76%)
42% less capital invested
Capital invested by funds: $287M → $166M (-$122M)
43% less call options, than puts
Call options by funds: $35K | Put options by funds: $61K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$5.89M |
| 2 |
EP
Eversept Partners
New York
|
+$2.46M |
| 3 |
Renaissance Technologies
New York
|
+$2.16M |
| 4 |
Millennium Management
New York
|
+$1.86M |
| 5 |
Two Sigma Advisers
New York
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
-$12.8M |
| 2 |
EA
Emerald Advisers
Leola,
Pennsylvania
|
-$6.13M |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$5.69M |
| 4 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$2.9M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.95M |
TECX Hedge Fund Activity: Q3 2021 in Review
99 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Tectonic Therapeutic (TECX) for Q3 2021, worth a combined $166M — down 42% from $287M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new TECX positions and 16 closed out — a net gain of 3 holders — while 34 added to existing stakes and 27 trimmed.
The largest buyer was MPM BioImpact, opening a new position worth an estimated $5.89M. The largest seller was State Street, cutting an estimated $12.8M.
- 99 institutional investors held Tectonic Therapeutic (TECX) as of Q3 2021, up from 97 in Q2 2021.
- Funds reported $166M of Tectonic Therapeutic stock for Q3 2021, down 42% quarter-over-quarter.
- 19 funds opened new Tectonic Therapeutic positions in Q3 2021 and 16 closed out, a net change of +3 holders.
- The largest Tectonic Therapeutic buyer in Q3 2021 was MPM BioImpact, an estimated $5.89M added.
- The largest Tectonic Therapeutic seller in Q3 2021 was State Street, an estimated $12.8M sold.
Based on aggregated 13F filings for Q3 2021.